- Home
- BVS vs CNNE Comparison
BVS vs CNNE Comparison
Compare BVS & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BVS | CNNE |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.1M | 608.0M |
| IPO Year | 2016 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BVS | CNNE |
|---|---|---|
| Price | $9.18 | $10.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $14.00 | ★ $21.33 |
| AVG Volume (30 Days) | 388.1K | ★ 721.8K |
| Earning Date | 03-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 5.45% |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $568,087,000.00 | $499,700,000.00 |
| Revenue This Year | $7.43 | N/A |
| Revenue Next Year | $6.61 | N/A |
| P/E Ratio | $28.06 | ★ N/A |
| Revenue Growth | N/A | ★ 3.37 |
| 52 Week Low | $5.81 | $10.46 |
| 52 Week High | $9.56 | $21.96 |
Technical Indicators
Market Signals| Indicator | BVS | CNNE |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 37.38 |
| Support Level | $7.04 | N/A |
| Resistance Level | $9.53 | $16.41 |
| Average True Range (ATR) | 0.31 | 0.42 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 90.04 | 30.77 |
Price Performance
Historical ComparisonAbout BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.